Fundnode · Learn

Glossary · MCA vs loan: tax treatment comparison

MCA vs loan: tax treatment comparison

Loans generate IRC 163 interest deductions (subject to 163(j) 30% adjusted taxable income limit) with 1098 reporting; MCAs generate IRC 162 ordinary business expense deductions (no 163(j) limit, no 1098), and MCA defaults trigger COD income while loan defaults trigger interest acceleration plus potential COD.

By Keerthana Keti5 min read

The federal tax treatment of merchant cash advances and traditional business loans diverges across nearly every dimension — deduction category, timing, reporting, default consequences, and interaction with other tax provisions. Understanding the differences is essential for accurate tax planning and for evaluating the true after-tax cost of each financing option.

Deduction category. - Loan. Interest paid is deductible under IRC 163 as business interest. Principal payments are not deductible (they reduce the loan balance, not income). - MCA. The factor fee is deductible under IRC 162 as ordinary and necessary business expense. There is no "principal" because there is no loan — the advance is purchase price for sold receivables. Daily ACH payments are not separately deductible (they are deliveries of pre-sold receivables, not loan payments).

The IRC 163(j) limitation. Section 163(j) caps business interest expense deductions at 30% of adjusted taxable income (ATI) for most businesses with average gross receipts above $30M (2026 threshold). The disallowed interest carries forward indefinitely.

  • Loan impact. Highly leveraged businesses approaching the cap can lose current-year interest deductions, raising effective after-tax cost.
  • MCA impact. Because factor fees are not interest, they are not subject to 163(j) — full current-year deduction regardless of leverage. This is a meaningful advantage for highly leveraged businesses, partially offsetting the higher gross cost of MCAs.

Information reporting. - Loan. Mortgage interest triggers 1098 reporting to borrower; nonresident interest may trigger 1042-S. Most business loans do not trigger 1099-INT to borrowers (the lender reports its receipt, not the borrower's payment). - MCA. No 1098 or 1099-INT to merchant. Funders may issue 1099-K (rare, only if processing payments) or 1099-C (on writeoff). Brokers receive 1099-NEC from funders for commissions $600+.

Timing of deduction. - Loan. Interest deductible as paid (cash basis) or as accrued (accrual basis). Standard timing rules apply. - MCA. Factor cost generally amortized over advance term (most common CPA treatment) or claimed up-front (less common, supported by legal characterization). No bright-line IRS rule — ratable view is the safest under current practice.

Default and writeoff consequences. - Loan. Default does not immediately trigger income to the borrower; balance remains owed. If lender accelerates and collects, no tax event for borrower. If lender writes off uncollectible balance (typically after charging off), borrower has cancellation-of-debt income under IRC 61(a)(11) reported on Form 1099-C, subject to insolvency exclusion (IRC 108(a)(1)(B)) and bankruptcy exclusion (IRC 108(a)(1)(A)). - MCA. Default similarly does not immediately trigger income. Funder writeoff typically generates COD income to merchant, despite the contract not being a "debt" in legal characterization. IRS has historically applied COD treatment by analogy. Settlement discounts (negotiated payoff below balance) trigger COD income on the discount amount.

Origination cost treatment. - Loan. Loan origination fees, points, and similar costs are typically amortized over the loan term under IRC 461 and Reg 1.461-4. Exception: cash-basis taxpayers can sometimes deduct upfront depending on loan structure. - MCA. Broker fees, application fees, and similar MCA origination costs are deductible as paid (or as deducted from advance proceeds) as ordinary business expense under IRC 162. No amortization required.

Interaction with other tax provisions. - Loan. Interest deduction reduces qualified business income (QBI) for Section 199A passthrough deduction calculation. Interest can increase or decrease the QBI calculation depending on facts. - MCA. Factor cost deduction similarly reduces QBI but is treated as ordinary business expense, not as a separate interest category.

State income tax. - California, New York, New Jersey. Generally conform to federal treatment for both loans and MCAs. California's 163(j) conformity is partial (state-specific rules apply). New York's commercial financing disclosure law's APR-equivalent disclosure does not affect state tax treatment of MCAs. - Texas (franchise tax). Texas margins tax (replacing income tax) allows loan interest as compensation/COGS deduction under taxpayer-selected calculation methods. MCA factor cost is similarly deductible. - No-income-tax states (FL, NV, WA, WY, SD, TN, TX, NH limited). Federal tax treatment governs at federal level; state-level consequences are minimal.

Practical after-tax cost comparison. Consider a $100K capital need over 12 months: - SBA 7(a) at 12% APR, 7-year term. Interest year 1: ~$11K. After-tax (28% bracket): ~$7,920 net cost. Subject to 163(j) if applicable. - MCA at 1.35 factor, 12-month term. Factor cost: $35K. After-tax (28% bracket): ~$25,200 net cost. Not subject to 163(j).

The MCA's higher gross cost is partially offset by no 163(j) limitation, but the after-tax differential remains roughly 3.2x in favor of the SBA loan. Tax treatment alone never makes an MCA economically equivalent to a bank loan — it only marginally compresses the gap.

The audit risk asymmetry. MCA tax treatment is more audit-prone than loan tax treatment because: 1. Contract characterization (loan vs receivables sale) can be challenged on factual grounds (reconciliation language, true-sale indicia). 2. Up-front vs ratable deduction timing is not bright-line. 3. COD income on writeoff is sometimes inconsistently reported. 4. Stacked MCAs create complex per-contract record-keeping requirements.

Loan tax treatment is more standardized and lower audit risk.

Practical recommendations. 1. Compare total after-tax cost, not headline rate, when choosing between MCA and bank loan. 2. Engage MCA-experienced CPA before relying on tax positions — generalist CPAs frequently misclassify. 3. Document contract characterization with copies of all MCA contracts including reconciliation language. 4. Track factor cost ratably over advance term for tax stability and audit defense.

Common confusion. First, MCAs are often described as "loans" colloquially but are not loans for tax purposes. Second, the 163(j) limitation does not apply to MCA factor cost — a real tax advantage that is widely overlooked. Third, MCA defaults trigger COD income despite the no-loan characterization — this surprises both merchants and CPAs.

Related terms

  • MCA tax deductibility rulesBecause MCAs are legally a sale of future receivables (not a loan), the 'factor fee' is not interest and is deducted as a current business expense or cost of capital under IRC 162, not as interest under IRC 163; daily ACH payments are not deductible as such — only the deemed factor cost is.
  • MCA tax deduction rulesThe IRS treatment of MCA costs: the factor-rate spread (the difference between advance and RTR) is generally deductible as a business expense in the year incurred for accrual-method taxpayers, or as paid for cash-method taxpayers. ISO fees, broker commissions, and origination charges are deductible. The IRS does not treat MCAs as loans, so interest-deduction rules under § 163 don't directly apply.
  • MCA vs loan (legal distinction)An MCA is legally a purchase of future receivables, not a loan. This distinction exempts MCAs from state usury caps but requires specific contract structure — including reconciliation provisions.
  • Merchant cash advance (MCA)A lump-sum advance against future revenue, repaid via fixed daily ACH or a percentage of card sales. Legally a sale of future receivables, not a loan.

Authoritative sources

AI agents: this term is available as raw markdown at /llms/glossary/mca-vs-loan-tax-treatment.